Guidance

APC guidance has been grouped according to BNF chapter.
Guidance includes
– Shared care guidance
– Clinical guidelines
– Information sheets – to help ongoing care in primary care following specialist initiation/recommendation.

Gastro-Intestinal System
Abnormal LFT Guidelines NENC Hepatology Network revised Nov 2016
Bariatric Prescribing and Monitoring Guidance for GPs V4
Prescribing Trans Anal Irrigation – guidelines for prescribing 2019 v2.0

Cardiovascular System
Angina GL (Updated 2014)
Atrial fibrillation – Prescribing for Non-valvular AF in Primary Care v2.0
Antiplatelet Guidelines – Mar 2017
Dronedarone SCG – Sept 17
FATS7 – Nov 2016
Hypertension Guidelines – 2017
Oral Anticoagulant Comparison Jan v2.1

Respiratory System
COPD management guidelines v2.0

Central Nervous system
Cognitive enhancing medication – leaflet for primary care v2.0
ADHD Adult shared care v1.0 Sept 2019
ADHD Children shared care Sept 2019 v1.0
Antipyschotic Leaflet September 2019 v2.0
Dexamfetamine for Narcolepsy SCG v1.0
APC position statement non-palliative care use of opiates

Headache Management Guidelines (Adult) – May 2016 Northern East Update, endorsed for use in North of Tyne and Gateshead areas – CURRENTLY UNDER REVIEW
Ketamine in Palliative Care Shared Care Guidelines – Aug 2017
Lithium-shared-care-update June 2019 v2.0
Melatonin – Children and Young People June 2018
Naltrexone SCG – May 2016
Vigabatrin SCG – Jul 2014

Infections and antibiotics
Nice Antimicrobial Guidance
Nebulised – Gentamicin Information-for-Primary-Care v2.0

Endocrine System
Denosumab Information leaflet 2018
Gender Dysphoria – Feminising Hormones – Mar 2017
Gender Dysphoria – Masculinising Hormones – Mar 2017
Thyroid Gudelines (TRAMP2) June 2018
Osteoporosis guidelines, including bisphosphonate review Dec 17
Liothyronine prescribing guidance v0.4

Genito-Urinary System
Erectile Dysfunction – Guidelines for the investigation and management of men with ED – Updated Sep 2015 – CURRENTLY UNDER REVIEW
Menopause guideline January 2019 v2.0
Non-Surgical Management of Overactive Bladder (OAB) pathway – Jan 2015
Urology Guideline – March 19
Methylphenidate for giggle incontinence – Children – July 2018
Catheter Formulary and guidance v2.0
Catheter info sheet v1.0

Renal Disease
NoT and Gateshead – CKD – Chronic Kidney Disease – Mar 2017
Renal Patients – Symptom Management v1.0

Malignant Disease and Immunosuppression
Guidelines for the Monitoring of Immune Modifying Drugs (IMDs) in Stable Adult Patients (excluding post transplantation in Primary and Secondary Care – July 2018
Immunosuppressive Treatment Following Liver Transplants SCG – Jun 2017
Immunosuppression following Paediatric renal transplantation SCG – Oct 17
Immunosuppressive Treatment following Renal Transplant – Dec 2016
Lanreotide and Octreotide July 2019 v2.0
Immunosuppressive Treatment for Paediatric Nephrotic Syndrome SCG – Oct 17
Tocilizumab-monitoring-shared-care-guidance-June-18 v1
NECN Palliative and End of Life Care guidelines 2016

Nutrition and Blood
Erythropoietin (Darbepoetin [Aranesp]) in the Treatment of Patients with CKD – Jul 17
Cinacalcet in primary hyperparathyroidism – 2020 final V4
Infant Formulae Prescribing Guidelines – Sep 2016
Vitamin D Quick reference guide v3.0
Vitamin B12 management v1.0
Gluten Free guidance Dec 18 (v2.1

Musculoskeletal and Joint Diseases

Ear, Eyes, Nose and Throat
ENT Guideline – Feb 2017
Eye conditions – NoT & G Guidelines for the management of common Opthalmology Conditions – Sep 2016

Skin
Acne management Guidelines v2.1

Diabetes
Blood-glucose-monitoring-guideline v2.0
Diabetes Stepped Approach guideline Jan 2019

Other Guidance
Brand name prescribing v 1.0 update
Prescribing-intervals Jan 2019
Seven-day-Rx-and-Monitored-dosage-systems Jan 2019
Stoma Prescribing Guidelines North of Tyne APC – Jan 2016
Swallowing-difficulties v2.0
Third party ordering – January 2019 (expiry date extension)